Patient Guide: A Randomized Phase II Study of Priming Treatment With the Hedgehog Inhibitor NLM-001 Prior to Gemcitabine/Nab-Paclitaxel (GNab-P) plusBotensilimab and Balstilimab (Bot/Bal) Versus GNab-P in Patients With Previously Untreated Advanced Pancreatic Cancer (NUMANTIA-2)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 6 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07578337
Status: UPCOMING
Condition: Untreated, Advanced Pancreatic Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 6 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Zaragoza, Aragon
  • Barcelona, Barcelona
  • Santander, Cantabria
  • • And 3 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily